Recently, the 2026 "Hand in Hand with Beijing-Tianjin-Hebei · Overseas Chinese Wisdom Gathering in Xiong'an" and New Overseas Chinese Innovation and Entrepreneurship Conference, guided by the Economic and Technological Department of the All-China Federation of Returned Overseas Chinese and co-hosted by the Hebei, Beijing, and Tianjin Federations of Returned Overseas Chinese, along with the Xiong'an New Area Party Working Committee, was grandly held in Xiong'an New Area, Hebei. As a technology-driven CDMO (Contract Development and Manufacturing Organization) enterprise, Laviana Pharma was invited to attend this grand event, gathering with overseas Chinese academicians, experts, scholars, and industry elites from 10 countries and regions to jointly discuss the gathering of overseas Chinese wisdom in Xiong'an and plan for a new industrial future.

Recently, the 24th World Pharmaceutical Raw Materials China Exhibition (CPHI China 2026) concluded successfully at the Shanghai New International Expo Centre. As a highly influential flagship industry event in the Asia-Pacific region, this exhibition gathered global pharmaceutical industry resources and built a platform for business matchmaking and technological exchange. Laviana Pharma made a significant appearance with its core business advantages, adopting an exclusive private meeting model to deepen industry collaboration, successfully completing its exhibition journey with fruitful results.

In June 2026. during the 25th National "Safety Production Month," and in order to deeply implement the activity theme of "Everyone Talks about Safety, Everyone Knows Emergency Response — Investigate and Rectify Risks and Hazards,"Laviana Pharma Cangzhou GMP Production Base carefully planned and organized a series of safety education activities with rich content and diverse forms. Through a multi-dimensional linkage of "theory + practice," "competition + drill," and "investigation + rectification," the activities comprehensively strengthened the company's safety production foundation and built a solid safety barrier for the company's high-quality development.

Recently, the Cangzhou Municipal Bureau of Industry and Information Technology released the 'Public Notice on the Second Batch of Municipal-Level Green Factory List in Cangzhou City.' Laviana Pharma (Cangzhou) Co., Ltd., due to its outstanding performance in green manufacturing, energy conservation and emission reduction, and intelligent production, successfully made the list and was recognized as a 'Municipal-Level Green Factory' after going through enterprise application, preliminary review recommendation, expert evaluation, and multi-department joint review.

Recently, DCAT Week 2026, an annual event with great influence in the global biopharmaceutical field, was grandly held in New York, USA. As a communication platform in the fields of global pharmaceutical supply chain and R&D & manufacturing services, this edition of the exhibition gathered enterprises, technology suppliers and industry decision-makers from dozens of countries and regions around the world, conducting in-depth exchanges and cooperation negotiations on core topics such as API R&D, formulation production, full-industry-chain CDMO services, green pharmaceuticals, and industrial collaborative innovation. Laviana Pharma made a high-profile appearance with its one-stop innovative pharmaceutical CDMO full-process solution package.

Recently, Laviana Pharma (Cangzhou) Co., Ltd. has been awarded the 'EcoVadis Gold' certification by the international authoritative corporate sustainability assessment organization EcoVadis in its latest rating, recognizing its outstanding performance in the four core areas of environment, labor and human rights, business ethics, and sustainable procurement. Its overall ranking has entered the top 5% of all assessed companies globally.